IQVIA Pharma Deals Review
ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.
Pharma Deals Review Latest Articles
-
Merck KGaA Pays C4 Therapeutics US$16 M Upfront for Protein Degraders
-
Gilead to Acquire CymaBay Therapeutics and its Liver Disease Drug for US$4.3 B
-
Sanofi Acquires Rare Disease Developer Inhibrx for up to US$2.2 B
-
Novartis to Acquire MorphoSys for US$2.9 B to Expand Oncology Pipeline
-
Novo Nordisk Signs US$252.6 M Deal with EraCal to Boost Obesity Portfolio
You can click on any of the bars to open a new page with the corresponding deals.